Royalty and Commercial Payment Purchase Agreements - Cost Recovery Method - Twist Bioscience (Details) $ in Thousands		12 Months Ended
	Oct. 21, 2024 USD ($) item Program	Dec. 31, 2025 USD ($)	Dec. 31, 2024 USD ($)
Agreements
Payments of consideration under RPAs, AAAs and CPPAs		$ 8,000	$ 53,000
Long-term royalty and commercial payment receivables under the cost recovery method		55,888	55,936
Short-term royalty and commercial payment receivables under the cost recovery method		0	$ 413
Royalty Purchase Agreement | Twist
Agreements
Contingent payments acquired (as a percent)	50.00%
Payments of consideration under RPAs, AAAs and CPPAs	$ (15,000)
Maximum milestone payments entitled to receive	$ 500,000
Royalties entity has right to receive (as a percent)	50.00%
Short-term royalty and commercial payment receivables under the cost recovery method		0
Allowance for credit losses		$ 0
Royalty Purchase Agreement | Twist | Maximum
Agreements
Number of early-stage programs | Program	60
Number of partners associated with programs | item	30